|
|
Home >
Anti-aging Research > Peroxisome Proliferator-activated Receptors
Peroxisome Proliferator-activated Receptors (PPARs))
Specific Recommendations:
News & Research:
-
A Pill to make Exercise Obsolete - The New Yorker, 11/6/17 -
"Iron Julius still takes 516, although lately he has
noticed a decrease in the drug’s quality. “I’m a volunteer firefighter so
stamina at times is very important,” he explained. “If you research, many
police and firefighters are on some form of performance-enhancing substance
as the jobs are sometimes physically demanding.” Iron Julius told me that
around a third of the people he sees at the gym are using 516, without any
side effects that he’s heard about. When I asked whether he would recommend
it, his response was, “Hell yeah man, try it. It don’t mess with hormones
and it increases performance.” ... So I ordered some. A few weeks later, a
twenty-milligram bottle of 516 arrived, taped into a sealed Tyvek envelope.
It was about the size of the complimentary shampoo you get in hotels and
contained a cloudy white liquid with a faint smell of nail-polish remover. A
label instructed me to “see accompanying information”—there wasn’t any—for
dosage instructions. Below that were two contradictory phrases: “Rx only”
and “Not for human consumption. ... ”I called Tim Willson, the drug’s
designer, to ask whether he would take it. “No,” he said, without
hesitation. I contacted the other researchers and found that none of them
had ever taken an exercise pill, in any form. I put the bottle to one side
of my desk while I pondered not only the advisability of ingesting a likely
carcinogen but also the fact that I actually enjoy exercise and get plenty
of it. Since then, the bottle has sat on my desk, undisturbed. During the
past month, its contents appear to have developed a faint, yellowish tinge."
-
Molecular 'switch' contributes to cellular aging process: Discovery suggests
new treatments for metabolic diseases - Science Daily, 11/30/10 -
"in older animals SMRT acts like a "switch," turning
off the protective cellular activities of proteins known as peroxisome
proliferator-activated receptors (PPARs). PPARs help regulate genes that
promote fat burning to maintain lipid (blood fat) balance and reduce
oxidative stress. The researchers were able to reduce the negative effects
of oxidative stress by giving antioxidants or drugs known to turn the
protective activities of PPARs back on ... PPAR drugs have been used to
increase insulin sensitivity and lower blood lipid levels ... we believe
SMRT is one of the key players that causes age-dependent decline in
mitochondrial function by blocking PPAR activity, and we've found a way to
boost the body's ability to better handle metabolic and oxidative stress"
- Note: There are several PARR receptor activators such as the blood
pressure drug
telmisartan and the diabetes medication
Actos (some doctors have
criticized me for years for taking it for anti-aging). When I get a chance
I'll search my site and put the articles on it.
|
|